Cited by 46Traumatic Brain Injury ResearchTraumatic Brain Injury and Neurovascular DisturbancesNeuroinflammation and Neurodegeneration Mechanisms

Toll like receptor 4 activation can be either detrimental or beneficial following mild repetitive traumatic brain injury depending on timing of activation

Corrigan, Frances, Arulsamy, Alina, Collins-Praino, Lyndsey E., Holmes, Joshua L., Vink, Robert·2017·Brain, Behavior, and Immunity

Abstract

A history of repeated concussion has been linked to the later development of neurodegeneration, which is associated with the accumulation of hyperphosphorylated tau and the development of behavioral deficits. However, the role that exogenous factors, such as immune activation, may play in the development of neurodegeneration following repeated mild traumatic brain injury (rmTBI) has not yet been explored. To investigate, male Sprague-Dawley rats were administered three mTBIs 5days apart using the diffuse impact-acceleration model to generate ∼100G. Sham animals underwent surgery only. At 1 or 5days following the last injury rats were given the TLR4 agonist, lipopolysaccharide (LPS, 0.1mg/kg), or saline. TLR4 activation had differential effects following rmTBI depending on the timing of activation. When given at 1day post-injury, LPS acutely activated microglia, but decreased production of pro-inflammatory cytokines like IL-6. This was associated with a reduction in neuronal injury, both acutely, with a restoration of levels of myelin basic protein (MBP), and chronically, preventing a loss of both MBP and PSD-95. Furthermore, these animals did not develop behavioral deficits with no changes in locomotion, anxiety, depressive-like behavior or cognition at 3months post-injury. Conversely, when LPS was given at 5days post-injury, it was associated acutely with an increase in pro-inflammatory cytokine production, with an exacerbation of neuronal damage and increased levels of aggr…

Integrity signals

Registry

Crossref · 10.1016/j.bbi.2017.04.006

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Delayed LPS treatment 5 days after repetitive TBI increased inflammatory cytokines, worsened neuronal damage including phosphorylation and aggregation of tau, and impaired behavioral recovery.

    “Delayed LPS treatment 5 days after repetitive TBI increased inflammatory cytokines, worsened neuronal damage including phosphorylation and aggregation of tau, and impaired behavioral recovery (235).”
  • LPS treatment 1 day after repetitive mild TBI (3 TBI's, 5 days apart) increased macrophage reactivity but decreased production of inflammatory cytokines and reduced neuronal injury.

    “For example, LPS treatment 1 day after repetitive mild TBI (3 TBI’s, 5 days apart) increased macrophage reactivity but decreased production of inflammatory cytokines and reduced neuronal injury (235).”
  • Timing of LPS treatment mediated a beneficial or detrimental post-injury effect in rats.

    “One group considered this question and determined that timing of LPS treatment mediated a beneficial or detrimental post-injury effect in rats.”

No citation lists for this paper

No citation lists for this paper yet — checked again daily.

References 99 · Cited by 46

Authors
Corrigan, F., Arulsamy, A., Collins-Praino, L. E., Holmes, J. L., & Vink, R.
Affiliations
  • The University of Adelaide (AU)
  • University of South Australia (AU)
Corresponding author
Corrigan, Frances
Venue
Brain, Behavior, and Immunity
Publisher
Elsevier BV
Published
2017-08
Volume
64
Pages
124-139
ISSN
0889-1591 (ISSN-L)
OpenAlex
W2606006288
Cited by
46
References
99
Citations by year
2026: 1 · 2025: 2 · 2024: 4 · 2023: 3 · 2022: 5 · 2021: 14 · 2020: 6 · 2019: 3 · 2018: 6 · 2017: 2
FWCI
3.64
Type
journal article
Language
en
Open access
closed
Locations
  • Brain Behavior and Immunity (publishedVersion)
  • PubMed (publishedVersion)
  • Adelaide Research & Scholarship (AR&S) (University of Adelaide) (submittedVersion)
Funders
Neurosurgical Research Foundation
Topics
  • Health Sciences › Medicine › Epidemiology › Traumatic Brain Injury Research
  • Health Sciences › Medicine › Neurology › Traumatic Brain Injury and Neurovascular Disturbances
  • Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
Keywords
TLR4, lipopolysaccharide, repetitive mild traumatic brain injury, concussion, neuroinflammation, microglial activation, inflammatory cytokines, interleukin-6, tau hyperphosphorylation, neurodegeneration, myelin basic protein, PSD-95, cognitive impairment, depression-like behavior
MeSH terms
Animals, Brain Concussion, Encephalitis, Lipopolysaccharides, Male, Motor Activity, Phosphorylation, Signal Transduction, tau Proteins, Rats, Sprague-Dawley, Microglia, Inflammation Mediators, Toll-Like Receptor 4, Illness Behavior

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review